Sun Pharmaceutical Industries Limited: Acne Vulgaris trials

The registry lists 30 Acne Vulgaris studies with Sun Pharmaceutical Industries Limited as lead sponsor. 0 are open to participants now and 8 have results posted.

Early Phase 1 5Phase 1 16Phase 2 2Phase 4 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With AcneCompletedNCT06415305Phase 4Results posted
• A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone PatientsCompletedNCT06415292Phase 4Results posted
• A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne PatientsCompletedNCT06415279Phase 4Results posted
• A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of AcneCompletedNCT06336629Phase 4Results posted
• A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of AcneCompletedNCT06336603Phase 4Results posted
• Efficacy Study in Patients With Acne Vulgaris.CompletedNCT02935036Phase 2Results posted
• ABSORICA in Patients With Severe Recalcitrant Nodular AcneCompletedNCT02457520Phase 4Results posted
• Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial AcneCompletedNCT00706433Phase 2Results posted
• A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne VulgarisCompletedNCT07469228Phase 1
• A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne VulgarisCompletedNCT06733402Phase 1
• A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.CompletedNCT06673641Phase 1
• A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne PatientsActive, not recruitingNCT06425900Phase 4
• A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne VulgarisCompletedNCT06063473Phase 1
• A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne VulgarisCompletedNCT04883736Early Phase 1
• A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne VulgarisCompletedNCT04797793Early Phase 1
• A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne VulgarisCompletedNCT04724473Early Phase 1
• Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne VulgarisCompletedNCT04321070Phase 1
• Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne VulgarisCompletedNCT04134273Phase 1
• To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne VulgarisCompletedNCT03433378Early Phase 1
• To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne VulgarisCompletedNCT03427554Early Phase 1
• Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne VulgarisCompletedNCT03132194Phase 1
• Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne VulgarisCompletedNCT02929719Phase 1
• Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne VulgarisCompletedNCT02709902Phase 1
• A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne VulgarisCompletedNCT02595034Phase 1
• A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne VulgarisCompletedNCT02578043Phase 1
• A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne VulgarisCompletedNCT02411955Phase 1
• Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne VulgarisCompletedNCT02411942Phase 1
• A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne VulgarisCompletedNCT01769664Phase 1
• Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne VulgarisCompletedNCT01769235Phase 1
• Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne VulgarisCompletedNCT01742637Phase 1